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Native Small Airways Secrete Bicarbonate
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University of California Riverside, Riverside, California
Abstract
Since the discovery of Cl2 impermeability in cystic ﬁbrosis (CF)
and the cloning of the responsible channel, CF pathology has
been widely attributed to a defect in epithelial Cl2 transport.
However, loss of bicarbonate (HCO3
2) transport also plays
a major, possibly more critical role in CF pathogenesis. Even
though HCO3
2 transport is severely affected in the native
pancreas, liver, and intestines in CF, we know very little about
HCO3
2 secretion in small airways, the principle site of morbidity
in CF. We used a novel, mini-Ussing chamber system to
investigate the properties of HCO3
2 transport in native porcine
small airways (z 1 mm f). We assayed HCO3
2 transport across
small airway epithelia as reﬂected by the transepithelial voltage,
conductance, and equivalent short-circuit current with
bilateral 25-mM HCO3
2 plus 125-mM NaGlu Ringer’s solution
in the presence of luminal amiloride (10 mM). Under these
conditions, because no major transportable anions other than
HCO3
2 were present, we took the equivalent short-circuit
current to be a direct measure of active HCO3
2 secretion.
Applying selective agonists and inhibitors, we show constitutive
HCO3
2 secretion in small airways, which can be stimulated
signiﬁcantly by b-adrenergic– (cAMP) and purinergic (Ca21)
-mediated agonists, independently. These results indicate that
two separate components for HCO3
2 secretion, likely via CFTR-
and calcium-activated chloride channel–dependent processes,
are physiologically regulated for likely roles in mucus clearance
and antimicrobial innate defenses of small airways.
Keywords: electrolyte transport; airway function; cystic ﬁbrosis
transmembrane conductance regulator; airway surface liquid;
mucus
Clinical Relevance
The authors describe a previously unknown basic
physiological function of normal small respiratory airways;
that is, the active secretion of bicarbonate (HCO3
2) into
airway surface liquids. Furthermore, they demonstrate
that secretion is not only constitutive, but can be enhanced
independently by either cystic ﬁbrosis (CF) transmem-
brane conductance regulator (CFTR)/cAMP–dependent or
calcium-activated chloride channel/Ca11–dependent
HCO3
2 secretory pathways. This discovery not only adds
new functions to the description of basic normal
physiology of the lung, but also provides the ﬁrst
physiological evidence in native small airway epithelia
to link the generalized defect in HCO3
2 transport in
CF to the most vulnerable region of respiratory
pathogenesis.
Even though cystic ﬁbrosis (CF)
transmembrane conductance regulator
(CFTR) mutations are well recognized for
disrupting Cl2 transport, major pathologies
associated with CF are closely associated
with defective bicarbonate (HCO3
2)
transport (1–10). The destruction of the
pancreas forces a focus on abnormal
HCO3
2 transport in CF pathology (2, 3,
11). Very recent evidence indicates that loss
of HCO3
2 secretion leads to abnormal
mucus maturation and poor release into the
lumens of the gut (12, 13) and the
reproductive tract (14), which may be at
play in other airway diseases as well. These
results specify a close link between
abnormal HCO3
2 transport and the
characteristically thickened mucus in
multiple organ systems that likely include
the small airways (15). In fact, abnormally
thick mucus formation (mucoviscidosis)
with consequent obstruction of small
airways is the foremost cause of morbidity
and mortality in patients with CF (16–18).
Although suspected for many years (1,
19–21), and despite this apparent nexus
between abnormal HCO3
2 secretion and
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abnormal mucus, whether HCO3
2
transport occurs in native small airways is
not yet known.
Until very recently, signiﬁcant
technical hurdles have precluded direct
physiological investigation of the miniscule
and fragile structures of native small
airways. We have now overcome several of
these limitations with a new system to
evaluate electrogenic responses of ion
transport in native small airways of roughly
1 mm diameter (22) using pigs as models
for function. The term “small airway” may
carry different implications in different
contexts. To clarify our use herein, we note
that, in adult humans, bronchi are typically
deﬁned as ciliated airways of more than 2
mm internal diameter that extend from the
trachea to approximate generations 7–9 in
the bronchial tree, are characterized by
rings of cartilage to prevent collapse, and
are associated with abundant submucosal
glands. By strict deﬁnition, bronchioles
(, 2 mm diameter) lack cartilaginous rings
as well as submucosal glands, are
collapsible, also ciliated, and extend beyond
bronchi to generations 15–19 (23, 24).
These airways are believed to be important
in inﬂammation in early chronic
obstructive pulmonary disease (24), asthma
(25), and CF (26).
In our young pigs, we cannot strictly
classify our roughly 1-mm-diameter
specimens as bronchioles, because plaques
of cartilage and some gland acini are
present, but neither do they qualify as
bronchi, because they lack both continuous
rings and signiﬁcant submucosal glands.
Thus, because they are small, and are most
likely to at least be from the zone of
transition to bronchioles in these young
pigs, we use the term “small airway” to refer
to the airways used in these studies.
We surmise that the properties of our
preparations reﬂect those of the mucosal
epithelium, because most maneuvers were
performed on the mucosal surface, avoiding
direct exposure to any functional gland
parenchyma that might be present.
Furthermore, contributions from glands
would require gland duct openings, which
would likely shunt the high diffusion
potentials that we observed. From the
histological similarity of the mucosal
epithelia in our preparations with that of
smaller, true bronchioles, we surmise that
major differences in electrolyte transport
properties with bronchioles are unlikely,
but conceivably possible.
Welsh and Smith (27) and Coakley
and colleagues (28) reported that HCO3
2
secretion occurs in normal, but not in CF,
cultured bronchial airway cells. However,
HCO3
2 secretion has never been
demonstrated in native, intact small airway
epithelium until now. We examined freshly
excised, native porcine small airways as
a model of human tissue to determine the
presence and physiological responses of
HCO3
2 secretion. We found constitutive
HCO3
2 secretion in small airways that is
stimulated signiﬁcantly by cAMP- and
Ca21-mediated agonists, and respectively
inhibited by selective antagonists, to suggest
two pathways of HCO3
2 secretion, possibly
via CFTR- and calcium-activated chloride
channels (CaCCs)–dependent transport.
Figure 1. Anion selectivity of small airways. Small airways show significant conductance to Cl2 and
bicarbonate (HCO3
2), as indicated by changes in transepithelial potential (Vt) and transepithelial
conductance (Gt) after anion substitution with 150 mM gluconate in the presence of 3-isobutyl-1-
methylxanthine (IBMX)/forskolin (Fsk) and amiloride in the luminal bath. Representative electrical trace
(A) of Vt responses to substitutions of 150 mM gluconate (black) on the lumen of a small airway with
equimolar HCO3
2 (gray) or Cl2 (white) while maintaining 150 mM NaCl on the serosal surface.
Summary of results of anion replacements on Vt (B) and Gt (C). Representative trace (D) of constitutive
electrical properties in bilateral 150 mM NaGlu with responses to substitution of 25 mM luminal Glu
with either equimolar Cl2 or HCO3
2, which significantly depolarized the electrogenic Na1-dependent
component of Vt. Note that Cl
2-induced depolarization was more than three times that due to
HCO3
2, indicating that HCO3
2 conductance is significantly greater than the impermeant gluconate,
but much less than Cl2 in shunting the Na1 absorptive potential. Summary of Vt (E) and Gt (F)
responses to replacements of 25 mM Glu2 (black) with equimolar HCO3
2 (gray) or Cl2 (white). 25HCO3
2,
25 mM NaHCO3
2; 25NaCl, 25 mM NaCl. *P , 0.05, **P , 0.001; data presented are means 6 SEM.
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Materials and Methods
Tissue Procurement and Preservation
Intact lungs were collected from farm pigs
(30–40 kg) of either sex immediately after
being killed by stunning, followed by
immediate exsanguination to reduce
pulmonary hemorrhage. Excised lungs were
placed in plastic bags under crushed ice
(, 108C) until being used (22). All
specimens reported were examined within
8 hours of death. The Institutional Animal
Care and Use Committee of the University
of California San Diego approved the
procedures used in this study.
Tissue Dissection and
Electrophysiological Measurements
To minimize endogenous prostaglandins
during dissection, indomethacin (1 mM)
was present in Ringer’s solution until
mounting the tissue. Approximately 4 mm2
of the opened and “ﬂattened” airway was
mounted with the serosal surface supported
by a “trampoline” of an open weave
polycarbonate mesh (400-mm openings;
salvaged from tea bags) in a custom-
fabricated mini-Ussing chamber (22). An
area (z 1 mm2) of the mucosal surface was
gently sealed under the polished end of
a small glass capillary (radius z 0.6 mm).
Both the apical and serosal sides of the
tissue were perfused with deﬁned solutions
at roughly 378C. The measurement of
transepithelial potential (Vt), calculations of
transepithelial conductance (Gt), and
equivalent short-circuit current (Isc
eq) have
previously been described in detail (22).
Brieﬂy, open-circuit Vt was measured
continuously with a high-impedance
voltmeter; Gt was calculated from Ohm’s
law based on the deﬂections in Vt during
Table 1: Constitutive and Agonist-Induced Transepithelial Electrical Properties of Small Airways
Vt Gt Isc
eq
Agonists (mV) (mS/cm2) (mA/cm2)
Constitutive
125 mM NaCl 1 25 mM NaHCO3 No agonists (n = 4) 22.3 6 1.3 14.2 6 3.8 22.1 6 9.8
125 mM NaGlu 1 25 mM NaHCO3 No agonists (n = 24) 21.2 6 0.3 7.7 6 0.8 10.6 6 1.4
DVt DGt DIsc
eq
(mV) (mS/cm2) (mA/cm2)
Mediators
cAMP Fsk/IBMX (n = 16) 1.7 6 0.3 1.0 6 0.2 15.0 6 1.6
IPR (n = 4) 1.3 6 0.4 0.4 6 0.2 10.2 6 1.2
Ca21 UTP (n = 10) 0.6 6 0.1 0.9 6 0.2 7.8 6 1.1
cAMP 1 Ca21 PGE2 (n = 4) 1.3 6 0.3 0.6 6 0.1 12.6 6 4.4
Fsk/IBMX 1 UTP (n = 5) 2.2 6 0.6 1.9 6 0.6 21.9 6 4.4
Definition of abbreviations: Δ, induced change from paired constitutive values; Fsk, forskolin; Glu, gluconate; Gt, transepithelial conductance; IBMX,
3-isobutyl-1-methylxanthine; IPR, isoproterenol; Isc
eq, equivalent short-circuit current; PGE2, prostaglandin E2; Vt, transepithelial potential.
Fsk (10 mM) plus IBMX (100 mM) and b-agonist, IPR (10 mM), were used as cAMP-mediated agonists. UTP (100 mM) was considered as an essentially
Ca21-mediated P2Y2 agonist, and PGE2 (1 mM) appeared to have properties of both a Ca21-mediated and cAMP-mediated agonist. NaHCO3
2
(25 mM) and NaGlu (125 mM) Ringer’s solutions were present bilaterally, and luminal amiloride (10 mM) was present to inhibit epithelial Na1
channel–dependent Na1 transport in all conditions. Constitutive values: Vt, Gt, and Isc
eq. Induced changes from paired constitutive values: ΔVt, ΔGt,
and ΔIsceq (n = number of measurements in as many tissues; values are means 6 SE).
Figure 2. Effect of cAMP agonist Fsk/IBMX and inhibitors on HCO3
2 transport. (A) Representative
trace of electrogenic HCO3
2 transport properties in native small airways with 25 mM HCO3
2 in
both basolateral and luminal baths (Cl2 free). In the presence of luminal amiloride (Amil), mucosal
addition of Fsk/IBMX significantly hyperpolarized Vt and stimulated equivalent short-circuit current
(Isc
eq). Luminal addition of cystic fibrosis (CF) transmembrane conductance regulator (CFTR) inhibitor,
GlyH-101 blocked the Isc
eq response. Furthermore, addition of serosal 4,49diisothiocyanostilbene-
2,29-disulfonic acid (DIDS) plus acetazolamide reduced the Isc
eq to significantly less than the initial,
unstimulated constitutive current (white). Summary of the effects of Fsk/IBMX (black), GlyH-101 (gray), and
DIDS1 acetazolamide (stippled) on Vt (B), Gt (C), and Isc
eq (D). *P, 0.05; data presented are means6 SEM.
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brief (1 s) constant current pulses (0.3–1.0
mA) passed intermittently (0.1 Hz) across
the tissue. Isc
eq was calculated from Gt and
Vt using Ohm’s law. As before (22), because
a 150-mM Cl2 gradient in well preserved
preparations of tissue generally generates
approximately 40 mV (lumen negative),
we discarded preparations that did not
generate a Vt more negative than 225 mV
with this gradient.
Solutions and Drugs
Ringer’s solution contained Na1 (150 mM),
K1 (4.6 mM), Mg21(1.0 mM), Ca21(1.0
mM), PO4
32 (2.5 mM), Cl2 (150 mM),
SO4
21 (1.0 mM), acetate (2.0 mM), and
glucose (10 mM), buffered to pH 7.4 with
HCl. For anion diffusion studies, 150 mM
NaCl was replaced with equimolar Na1
gluconate (150-mM Cl2 gradients). For
NaHCO3
2 Ringer’s solution, 25 mM
NaHCO3
2 plus 125 Na1 gluconate were
substituted for Cl2 as indicated. All HCO3
2
solutions were adjusted to pH 7.4 by gassing to
equilibrium with 95% O2 plus 5% CO2.
3-Isobutyl-1-methylxanthine (IBMX;
100 mM), forskolin (Fsk; 10 mM),
prostaglandin E2 (PGE2; 1 mM),
isoproterenol (IPR; 10 mM), UTP
(100 mM), ATP (100 mM), amiloride
(10 mM), indomethacin (1 mM),
4,49diisothiocyanostilbene-2,29-disulfonic
acid (DIDS; 100 mM), acetazolamide
(100 mM), 4,49-dinitrostilbene-2,29-
disulphonic acid (DNDS; 100 mM),
niﬂumic acid (NFA; 100 mM), mecholyl
(10 mM), substance P (1.0 mM), and
vasoactive intestinal peptide (0.1 mM)
were obtained from Sigma Chemical Co.
(St. Louis, MO) and applied at the
concentrations indicated in parentheses.
GlyH-101 (50 mM), used as a CFTR inhibitor,
was a generous gift from Dr. A. Verkman
(University of California San Francisco).
HCO3
2 Transport Assay
All assays of electrogenic HCO3
2 transport
were performed in bilateral 25-mM HCO3
2
plus 125-mM NaGlu Ringer’s solution in
the presence of luminal amiloride to block
electrogenic Na1 absorption and prevent
Cl2 secretion. Because no major,
transportable ion other than HCO3
2 was
present, the changes in Vt, Gt, and Isc
eq after
stimulation were interpreted as due to
changes in HCO3
2 secretion activity. The
fact that known HCO3
2 transport
inhibitors almost completely blocked this
Isc
eq supported this interpretation.
Statistical Analysis
The data are presented as means (6 SE),
and “n” is the number of tissues. Statistical
signiﬁcance was determined on the basis of
Student’s t test for paired samples. A P
value less than 0.05 was taken as indicating
a signiﬁcant difference.
Results
HCO3
2 Conductance
We determined the apparent permeability of
HCO3
2 relative to Cl2 and the impermeant
anion, gluconate, in the presence of
amiloride. After stimulation with Fsk plus
IBMX, changes in Vt on replacing 150 mM
Cl2 in the apical bathing solution with 150
mM HCO3
2 or 150 mM gluconate (Figures
1A and 1B) indicated that the native airway
epithelium is approximately 1/5 as
permeable to HCO3
2 as to Cl2, as
calculated from the Goldman equation (29).
The value approximates the relative
conductances reported previously for the
CFTR channels in other preparations
(6, 30). Likewise, the ratio of Cl2 and
HCO3
2 conductances measured here
generated a similar ratio (Figure 1C). We
reduced the concentration of both
HCO3
2 and Cl2 to the physiological
concentration of 25 mM and repeated the
substitutions. These maneuvers (without
amiloride) resulted in shunting the
constitutive Vt, most likely due
electrogenic absorption of Na1 in the
absence of permeable anions. The fact
that Cl2 caused relatively greater changes
in Vt and Gt not only reveals the
inherently high Gt to Cl
2 compared with
HCO3
2(Figures 1D–1F), but also suggests
that Cl2 is the more prevalent co-ion in
electrogenic ﬂuid absorption (22).
Figure 3. Effects of inhibitor GlyH-101on isoproterenol (IPR) stimulation of HCO3
2 transport. (A)
Representative trace of changes in electrogenic HCO3
2 transport properties with addition of IPR (10 mM),
which significantly hyperpolarized Vt and stimulated Isc
eq (P, 0.05; n = 3). Luminal addition of inhibitor, GlyH-
101, blocked stimulated HCO3
2 secretion. Summary constitutive properties (white) and of the effects of IPR
(black) and GlyH-101 (gray) on Vt (B), Gt (C), and Isc
eq (D). *P , 0.05; data presented are means 6 SEM.
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cAMP-Mediated HCO3
2 Secretion
Effects of cAMP agonists and CFTR inhibitor
Gly-H 101. We ﬁrst tested the effect of
removing Cl2 from the media, after which
approximately 50% of the constitutive Isc
eq
remained (Table 1). To show that HCO3
2
secretion is responsive to stimulation, and
therefore likely to be a physiologically
regulated function, we tested different
agonists for effects on HCO3
2 Isc
eq by
elevating intracellular cAMP. Adding
membrane-permeable Fsk/IBMX to the
lumen (Figure 2) to elevate intracellular
cAMP directly or adding the cAMP-
mediated b-adrenergic agonist, IPR
(Figure 3), to the bath solution signiﬁcantly
increased Vt, Gt, and Isc
eq over constitutive
values, indicating activation of electrogenic
HCO3
2 secretion (i.e., Isc
eq more than
doubled). The CFTR inhibitor, GlyH-101 (22,
31, 32), in the lumen completely inhibited
the cAMP-stimulated response and reduced
the Isc
eq to constitutive (unstimulated) levels
(Figures 2 and 3; Table 1). Adding DIDS
and acetazolamide basolaterally after the
luminal inhibition with GlyH-101 to
Fsk/IBMX–stimulated airways to inhibit
any remaining HCO3
2-dependent current
further reduced Isc
eq to values that were
approximately 50% of the constitutive
values (Figure 2).
Applying basolateral DNDS (Figure 4)
to inhibit HCO3
2 entry into the cells via
basolateral sodium bicarbonate co-
transporter and/or Cl2/HCO3
2 transporters
also inhibited approximately 80% of the
stimulated response, and adding luminal
GlyH-101 to inhibit CFTR again reduced Isc
eq
to approximately 50% of the constitutive
values (Figure 4). We cannot account for the
residual current after applying these
inhibitors (which were also in the presence of
amiloride and absence of Cl2).
Effects of PGE2, GlyH-101, and NFA.
We applied the secretagogue, PGE2, to the
luminal solution. PGE2 increased Isc
eq to
more than twice the constitutive current,
but GlyH-101 did not completely inhibit
the stimulated increase. Adding the
putative Ca21 channel inhibitor, NFA,
reduced the Isc
eq to approximately 50% of
the constitutive values (Figure 5).
Ca21-Mediated HCO3
2 Secretion
Effects of UTP and inhibitor NFA. We
investigated the possibility that the Ca21-
activated P2Y2 purinergic receptor ligand,
UTP, might account for the GlyH-101
(possibly CFTR) –independent HCO3
2
secretion. In bilateral 25 mM NaHCO3
2,
UTP also signiﬁcantly stimulated
HCO3
2 secretion (Figure 6). Under these
conditions, Vt hyperpolarized as Gt and
Isc
eq signiﬁcantly increased, whereas all
three responses were inhibited by addition
of NFA, which decreased Isc
eq signiﬁcantly
below the initial spontaneous current
(Figure 6).
Additive Effects of cAMP- and
Ca21-Mediated Stimulation on
HCO3
2 Secretion
We investigated potential additive effects of
the cAMP-mediated agonist, Fsk/IBMX,
combined with the Ca21-mediated agonist,
UTP. We stimulated with Fsk and IBMX.
and Vt, Gt, and Isc
eq signiﬁcantly increased
(P , 0.05; n = 5). We then added luminal
UTP, which further increased Vt, Gt, and
Isc
eq (Figure 7; Table 1). The additive
responses were independent of the
sequence of adding the agonist (data not
shown).
Speciﬁcity of pathway inhibition. As
a ﬁnal test of independence of pathways, we
stimulated with Fsk/IBMX and then tested
inhibition of the response by adding NFA.
The inhibitor had no discernible effect
(Fsk/IBMX Isc
eq = 25.0 6 8.4 uA/cm2
versus Fsk/IBMX1 NFA Isc
eq = 24.26 8.5;
P . 0.08; n = 4). Likewise, we stimulated
with UTP and then inhibited with Gly-H-
101. Similarly, the CFTR inhibitor did
not block the UTP response (UTP Isc
eq =
28.2 6 3.8 versus UTP Isc
eq 1 Gly-H-101 =
28.1 6 3.9; P . 0.42; n = 3).
Other Agonists
We also tested for the effects of other
agonists, including mecholyl, substance P,
Figure 4. Effect of the inhibitors 4,49-dinitrostilbene-2,29-disulphonic acid (DNDS) and GlyH-101 on
Fsk/IBMX stimulation. (A) Representative trace of electrogenic HCO3
2 transport properties after
luminal addition of Fsk/IBMX (black), which significantly hyperpolarized Vt, increased Gt, and
stimulated Isc
eq in the continuous presence of luminal amiloride (white). Subsequent contraluminal
addition of the inhibitor DNDS (gray) significantly blocked Vt, Gt, and Isc
eq response (P , 0.05; n = 3).
Further luminal addition of GlyH-101 (stippled) reduced the remaining Isc
eq to significantly less
than the initial constitutive current. Summary of the effects of Fsk/IBMX (black), DNDS (gray), and
GlyH-101 (stippled) on Vt (B), Gt (C), and Isc
eq (D). *P , 0.05; data presented are means 6 SEM.
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and vasoactive intestinal peptide. We
observed no detectable effects of any of these
agents (data not shown).
Discussion
Two clinical facts pointedly indicate that
human small airways should be capable of
secreting HCO3
2 physiologically. First,
HCO3
2 secretion is severely depressed or
absent in pathologically affected organs in CF
in general (1, 10, 15). Second, most
morbidity and mortality in CF are deﬁned by
failure in small airways (16–18). These
fundamental observations encompass the
additional facts that: (1) CFTR, the culprit
protein in CF, is localized along the apical
border of airway epithelia on ciliated cells
(31, 33); and (2) CFTR supports transport of,
and/or is permeable to, HCO3
2 (6, 8, 30).
Due to the small size, tedious
dissectability, and tubular branching
morphology of small airways, neither
physiological regulation, nor even HCO3
2
secretion itself, has been demonstrated in
native small airways. However, we recently
introduced a miniaturized Ussing chamber
(22) that permits very small specimens
of epithelia (z 1 mm f) to be examined
electrophysiologically, making it possible to
evaluate the electrogenic signatures of
electrolyte movements, including HCO3
2
transport. With this system, we used pig
small airways (z 1 mm f) as a model for
human tissue, especially because mutations
for CF in transgenic pigs have recently
become available experimentally (34, 35).
To test this tissue for the presence of
electrogenic HCO3
2-dependent properties,
we ﬁrst assayed for transepithelial HCO3
2
and Cl2 conductances using diffusion
potentials from imposed chemical
gradients. In the presence of a 150-mM
HCO3
2 gradient, the Vt was approximately
70% of that of an equivalent Cl2 gradient
(Figure 1), giving a selectivity ratio for Cl2:
HCO3
2 of approximately 5:1 (29), which
compares favorably with approximately 4:1
of the CFTR single-channel selectivity ratio
(6, 30), and seems consistent with the
presence of this channel on the luminal
surface of this epithelium (31). These
results suggest that the CFTR channel
conductance dominates the overall
epithelial ion selectivity under these
conditions, which would also include its
expression in secretory as well as absorptive
epithelial cells (22).
cAMP-Mediated HCO3
2 Secretion
Because mutations in CFTR are the basis
of CF, and because CFTR is activated
via increases in intracellular cAMP
concentration (11, 36), we ﬁrst tested the
effects of directly elevating intracellular
cAMP (with the adenylyl cyclase agonist,
Fsk, combined with the phosphodiesterase
inhibitor, IBMX). However, we observed
the presence, even before applying these
agents, of an unstimulated, constitutive Isc
eq
(mean = 10.6 6 6.6; range over all
experiments from z 5 to 20 mA/cm2). We
found that Fsk/IBMX doubled the
constitutive HCO3
2 Isc
eq, which was
effectively inhibited by the CFTR-selective
inhibitor, GlyH-101 (32) (Figure 2,
Table 1). These responses further illustrate
the physiological presence of CFTR-
dependent HCO3
2 secretion in the small
airways. To test whether this secretion
might involve physiological b-adrenergic
regulation through G protein receptors, we
applied the well known cAMP-mediated
b-adrenergic agonist, IPR, and found that it
also doubled the constitutive HCO3
2 Isc
eq,
which was also blocked by GlyH-101
(Figure 3, Table 1). These results strongly
advocate for a CFTR-dependent pathway of
HCO3
2 secretion in this tissue.
Unexpectedly, however, during these
assays, we observed that adding inhibitors in
addition to GlyH-101 to inhibit secretion
by blocking HCO3
2 entry into the epithelial
cells via possible Na1-dependent HCO3
2
cotransporters and/or Cl2/HCO3
2
exchangers, such as DIDS or DNDS
(37, 38), reduced the HCO3
2 Isc
eq to
signiﬁcantly less than the constitutive Isc
eq
(Figures 2 and 4). This result suggests the
presence of another mechanism or pathway
Figure 5. Effects of inhibitors, GlyH-101 and niflumic acid (NFA), on prostaglandin E (PGE) -2
stimulation. (A) Representative trace of electrogenic properties of HCO3
2 transport stimulated by
luminal PGE2 (black; 1 mM). Vt hyperpolarized and Isc
eq increased significantly (P , 0.05; n = 4).
Luminal addition of inhibitor, GlyH-101 (gray), significantly decreased the HCO3
2 secretion, and
further addition of the Ca21-activated chloride channel (CaCC) antagonist, NFA (stippled), further
depressed the HCO3
2 secretion to levels significantly below the initial constitutive value. Summary
of the effects of PGE2 (black), GlyH-101 (gray), and NFA (stippled) on Vt (B), Gt (C), and Isc
eq (D).
*P , 0.05; data presented are means 6 SEM.
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for electrogenic HCO3
2 secretion in
addition to CFTR-dependent transport. We
cannot exclude the possibility that GlyH-
101 conceivably did not completely block
the CFTR-dependent path or that DIDS
and DNDS may have had a nonspeciﬁc
effect.
Ca21-Mediated HCO3
2 Secretion
We examined the possibility that another
signaling pathway might be mediated from
the luminal surface, possibly via Ca21-
mediated purinergic receptors in the apical
membrane (39–42). We tested the effect of
adding the purinergic P2Y2 agonist, UTP,
to the luminal bath, which, in fact, also
signiﬁcantly stimulated HCO3
2 Isc
eq
(Figure 6, Table 1). Applying luminal NFA
to inhibit CaCC not only blocked the
stimulated current, but also decreased the
total current to signiﬁcantly less than the
constitutive Isc
eq (Figure 6). Noting that
PGE2 is a potent mucin secretagogue and
may act via both cAMP and Ca21
mediators (43, 44), we observed that, when
we stimulated with this agonist, the Isc
eq
more than doubled, but GlyH-101 only
partially blocked the increase (Figure 5);
again, adding NFA to block possible CaCC-
dependent activity (45, 46) further inhibited
the HCO3
2 Isc
eq to signiﬁcantly below the
initial constitutive current (Figure 5).
We surmised that, if HCO3
2 were
secreted by separate components
independently, concurrently stimulating
the tissue with both cAMP- and Ca21-
mediated agonists together might increase
HCO3
2 Isc
eq more than either agonist
alone. That is, the responses might be
additive, which appeared to be the case
(Figure 7, Table 1). Taken together, these
results support the notion of two separate
pathways for HCO3
2 secretion in the small
airways. We tentatively assume that
a CFTR-dependent mechanism under
b-adrenergic control is present, but
independent of another mechanism
possibly under purinergic control acting via
CaCC-dependent secretion. Although
CaCCs were not initially thought of as
major HCO3
2 conductances, very good
evidence has been presented for that role in
oviduct tissue (47), and more recent
evidence suggests that they may play such
a role in goblet cells (48). The notion that
Cl2 channels also physiologically transport
HCO3
2 is not widely recognized, and has
generally given way to a more classical view
in which an apical Cl2/HCO3
2 anion
exchanger operates in parallel with a Cl2
conductance that recycles Cl2 effecting net
HCO3
2 secretion (49). However, it does
not seem possible that Cl2-dependent
transport could be involved in our
measurements, because Cl2 was absent
from both apical and basolateral solutions.
This conclusion does not in any way rule
out the function and contribution of anion
exchangers when Cl2 is present physiolog-
ically, which would only add to the
tissue’s capacity to transport HCO3
2.
Why Two?
The suggestion of two independent
mechanisms for HCO3
2 secretion begs the
question of “why two”? Although only
guided speculation is possible at this point,
it is intriguing to note that two new roles
for HCO3
2 have come to light very recently
beyond its conventional role as the
principal extracellular physiological buffer.
First, HCO3
2 was discovered to be critical
for the bactericidal properties of
antimicrobial peptides (AMPs) (50).
Moreover, Pezzulo and colleagues (51)
reported recently that the relatively more
acidic airway surface ﬂuid (most likely due
to the lack of HCO3
2) in CF transgenic pig
airways failed to kill bacteria as efﬁciently
as in wild-type pigs. Second, secreted
HCO3
2 was also discovered to be crucial
for the normal release and maturation of
gel-forming mucins (12–15). Needless to
point out, both of these functions are
inherent in and crucial for innate defense of
airways. Where and how HCO3
2 is
secreted for AMP activity has not been
considered, and conceivably could be under
partial or separate Ca21-mediated control
(52). Likewise, the source of HCO3
2 for
normal mucin maturation has not been
ﬁrmly established either, but appears to be
mainly via cAMP-mediated stimulation of
enterocytes in the small intestine (53).
Because UTP acts via purinergic receptors
and IPR acts via adrenergic receptors, we
question whether the former might be
Figure 6. Effects of inhibitor, NFA, on UTP stimulation. (A) Representative trace of changes in
electrical properties reflecting HCO3
2 transport induced by luminal addition of UTP (black; 100 mM),
which significantly hyperpolarized Vt, increased Gt, and stimulated Isc
eq (P , 0.05; n = 5). Luminal
addition of the CACC inhibitor, NFA (gray), decreased the HCO3
2 secretion Isc
eq to values significantly
less than initial constitutive secretion in the continuous presence of luminal amiloride (white).
Summary of the effects of UTP (black) and NFA (gray) on Vt (B), Gt (C), and Isc
eq (D). *P , 0.05; data
presented are means 6 SEM.
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associated more with AMP pathogen
defense and the latter with mucin clearance
defense.
The possibility of two independent
HCO3
2 sources in the airways raises
a propitious hope for potential
pharmacotherapeutics for CF (54, 55) and
possibly other diseases. That is, in CF for
example, pharmacologically stimulating
a Ca21-mediated source of HCO3
2
secretion independent of CFTR might
enhance the effectiveness of AMP killing
and/or signiﬁcantly enhance a more normal
discharge of goblet cell mucins and mucus
in small airways.
Conclusions
In summary, native small airway epithelia
appear to secrete HCO3
2 by at least two
separate pathways. One pathway appears to
be CFTR dependent and appears to be
cAMP mediated via b-adrenergic receptors.
The other pathway appears to be CaCC
dependent, possibly via Ca21-mediated
luminal purinergic receptors. These
HCO3
2 secretions in the small airways
would not only serve a conventional role as
a pH buffer, but also critically support the
maturation and discharge of mucins as well
as the bactericidal activity of AMPs for
innate defense. Defects in HCO3
2 secretion
seem likely to predispose the innate
defenses of small airways to pathogenic
failure, as seen in CF. n
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